Regional News
Eye Level Launches New Visual Communication Design to Celebrate Its 11th Anniversary of Rebranding
SEOUL, South Korea, May 8, 2023 /PRNewswire/ -- Eye Level, a leading educational institution that provides personalized learning for children, has launched a new visual communication design to commemorate its 11th anniversary of rebranding. The institution's new design reflects the evolution of i...
2023-05-08 09:49
2922
Livestock Malaysia 2023 - Stronger and better in its comeback
KUALA LUMPUR, Malaysia, May 8, 2023 /PRNewswire/ -- The doors of the Kuala
Lumpur Convention Center will open once more to Malaysia's premier livestock
show that will gather exhibitors and visitors from all over the world to see
the latest innovations in the meat and feed industries.
2023-05-08 09:31
3829
Eye Level Launches New Visual Communication Design to Celebrate Its 11th Anniversary of Rebranding
SEOUL, South Korea, May 8, 2023 /PRNewswire/ -- Eye Level, a leading educational institution that provides personalized learning for children, has launched a new visual communication design to commemorate its 11th anniversary of rebranding. The institution's new design reflects the evolution of i...
2023-05-08 09:02
3434
Veeva Unveils Vault CRM, Next Generation of CRM for Life Sciences
Delivers significant innovations for the industry including AI-powered CRM Bot, integrated Service Center, and full functionality of Veeva CRM SINGAPORE, May 8, 2023 /PRNewswire/ -- In a showcase demo kicking off Veeva's 2023 North America Commercial Summit to an audience of nearly 1,500 life sc...
2023-05-08 09:00
4793
With support of the Monarchy and Commonwealth of 2.6 billion people in 56 Commonwealth countries, a tribute song to HM King Charles lll has been released internationally.
TORONTO, May 8, 2023 /PRNewswire/ -- KING OF THE COMMONWEALTH/ JUST YOU WAIT AND SEE was composed for a very special dedication to His Majesty on his Coronation Day by Canadian singer/ songwriterLeesa Kaczmarzyk. The lyrics of the song welcome the new Modern King with references to His late pa...
2023-05-08 08:41
2489
World Lupus Federation Urges Global Community to Raise Lupus Awareness on May 10 for World Lupus Day 2023
Lupus awareness tools, facts and resources available at WorldLupusDay.org/tool-kit WASHINGTON, May 8, 2023 /PRNewswire/ -- World Lupus Day was established to take place onMay 10 by the World Lupus Federation (WLF) to unite lupus groups around the world during Lupus Awareness Month and call atten...
2023-05-08 08:00
3972
Innovent Updates the Results from the ORIENT-31 Study of Sintilimab Plus Chemotherapy With or Without Bevacizumab in Patients with EGFR-TKI failed EGFR-mutated Non-Squamous Non-Small Cell Lung Cancer in the Lancet Respiratory Medicine
ROCKVILLE, Md. and SUZHOU, China, May 8, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...
2023-05-08 08:00
5921
Duoning Biotech Celebrates Ground Breaking for Its Global Headquarters
SHANGHAI, May 8, 2023 /PRNewswire/ -- On May 6th, the "2023 Commencement Ceremony for Major Industrial Projects in Fengxian and for Duoning's Global Headquarters and Industrialization Base" was held grandly in the Biotechnology Park. Leaders of the Fengxian district, representatives of the Orient...
2023-05-08 08:00
4402
Innovent Announces First Participant Dosed in Phase 3 Study (RESTORE) of IBI311 (Anti-IGF-1R Monoclonal Antibody) in Patients with Thyroid Eye Disease
ROCKVILLE, MD. and SUZHOU, China, May 8, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and ...
2023-05-08 08:00
5390
Universities Around the World Compete to Improve Accessibility using Anthology Ally
Anthology's Annual Global Fix Your Content Day is May 18 BOCA RATON, Fla., May 8, 2023 /PRNewswire/ -- Anthology, a leading provider of education solutions that support the entire learner lifecycle, today announced its fourth annualFix Your Content Day to highlight the need for more inclusi...
2023-05-08 07:00
2760
BLISS BIOPHARMACEUTICAL ENTERS INTO A CLINICAL TRIAL COLLABORATION AGREEMENT WITH AN OPTION OF STRATEGIC COLLABORATION WITH EISAI FOR BB-1701
HANGZHOU, China, May 7, 2023 /PRNewswire/ -- Bliss Biopharmaceutical (Hangzhou) Co., Ltd, ("BlissBio") a clinical-stage biopharmaceutical company developing differentiated antibody-drug conjugate (ADC) therapeutics, announced a clinical trial collaboration agreement with option for strategic coll...
2023-05-08 07:00
2878
Telix to Supply Bayer with Illuccix® for Global Phase III Prostate Cancer Study, including Japanese Sites
MELBOURNE, Australia and KYOTO, Japan, May 8, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement with Bayer AG (Bayer) to supply Illuccix® (TLX591-CDx, kit for the preparation of gallium Ga 68 gozetotide injectio...
2023-05-08 05:00
3826
Telix to Supply Bayer with Illuccix® for Global Phase III Prostate Cancer Study
MELBOURNE, Australia, May 8, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an agreement with Bayer AG (Bayer) to supply Illuccix® (TLX591-CDx, kit for the preparation of gallium Ga 68 gozetotide injection)[1] for the Pha...
2023-05-08 05:00
6528
NEW THERAPY FOR RARE GASTROINTESTINAL STROMAL TUMOURS APPROVED IN SINGAPORE
* Singapore's Health Sciences Authority (HSA) has approved QINLOCK® (ripretinib) for the treatment of patients with 4th line GIST * QINLOCK significantly reduced the risk of disease progression or death by 85% and showed clinically meaningful overall survival in theINVICTUS Phase 3 Study1,2 ...
2023-05-08 04:00
2874
VENUSTAS Launches the First Crowdfunding Campaign for Heated Camping Chair on Kickstarter
LITTLETON, Mass., May 7, 2023 /PRNewswire/ -- VENUSTAS
2023-05-07 21:00
2838
China Cycle 2023: CST debuts CST COREX two-wheeled tire product, promotes sustainable development for ESG project globally
SHANGHAI, May 7, 2023 /PRNewswire/ -- Cheng shin Rubber (Xiamen) IND., LTD.
("CST"), a leading manufacturer of two-wheeled tires, has launched CST COREX,
an innovative product built with ECO-RE technology at the 31st China
International Bicycle Fair (China Cycle 2023).
2023-05-07 12:56
3823
Hisense Named to Fortune China's ESG Influential Listing 2023
QINGDAO, China, May 6, 2023 /PRNewswire/ -- Hisense, the consumer technology brand and a major international provider of home appliances, has once again been named to Fortune China's ESG Influential Listing, for its excellent performance in the fields of technology research and development, manu...
2023-05-06 22:00
7262
China's self-developed AR glasses X-Craft won the gold medal at the Geneva International Invention Exhibition
HANGZHOU, China, May 6, 2023 /PRNewswire/ -- Recently, the 48th Geneva International Invention Exhibition was held at the Palexpo Exhibition Center in Geneva, Switzerland, with over 800 exhibitors from 40 countries displaying more than 1,000 innovative projects. During the exhibition, 165 inventio...
2023-05-06 21:34
3290
Wait… What? Oscar-winning filmmakers are using this portable projector from JMGO???
The projector showcases JMGO's relentless pursuit of cinematic picture quality
and the commitment to upgrading the viewing experience for global users.
SHENZHEN, China, May 6, 2023 /PRNewswire/ -- JMGO N1 Ultra Triple Color Laser
Gimbal Projector has securedUS$2.24 million on Kickstarter
2023-05-06 21:00
3749
Suzhou GenAssist Therapeutic Co.,Ltd recently announced that its first base editing product, GEN6050, has submitted a pre-IND application to the FDA and has been accepted
SUZHOU, China, May 6, 2023 /PRNewswire/ -- Suzhou GenAssist Therapeutic Co.,Ltd recently announced its pre-IND application of their first base editing product, GEN6050 and the acceptance by the FDA. GEN6050 is an in vivo base editing drug that targets exon 50 skipping in the Duchenne muscular...
2023-05-06 21:00
5429
Week's Top Stories
Most Reposted
HLB's Flagship CIO Fund Launched with Strategic Alliance with Lombard Odier
[Picked up by 280 media titles]
2026-09-28 23:04
Responsible Fintech Institute Appoints Four Executive Fellows and Elevates Distinguished Professor Patrick H. M. Loh to Co-Founder
[Picked up by 279 media titles]
2026-09-29 09:00
Allianz Partners unveils next-generation travel insurance platform to help partners navigate changing landscape
[Picked up by 269 media titles]
2026-09-28 07:30
Zenika CTO Adrien Nortain Moves Base to Singapore to Strengthen Technical Leadership in Asia
[Picked up by 267 media titles]
2026-10-01 10:00
ViewSonic Launches VG1457 Dual-Screen Portable Monitor for Productivity Anywhere
[Picked up by 267 media titles]
2026-09-30 10:50
Most Read
Brightray Signs Prefabricated Module Sales Framework Agreement for Planned 40MW AI Data Center Project in Macao
2026-09-25 20:30
14383
Envision Energy Secures TÜV SÜD Certificate for Wind Farm Control System, Strengthening Long-Term Resilience for Future Energy Systems
2026-09-25 20:11
13047
ULTRALOQ Launches Next-Generation Smart Lock Collection: Refining Home Entry with Natural, Intelligent and Trusted Access Solutions
2026-09-26 02:46
12195
